SCHEMBL20107459

SCHEMBL20107459

CC(C)CC(C)OP(=O)(OC(C)CC(C)C)SCC(C)O

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LAP3 P28838 4/20 0.34
ANPEP P15144 3/20 0.32
ERAP1 Q9NZ08 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25670440 0.96 LAP3 (0.33) LAP3ANPEPERAP1
SCHEMBL25670451 0.83 CTSA (0.31)
SCHEMBL20107503 0.82 CTSA (0.36)
SCHEMBL25670460 0.81 CYP3A4 (0.31)
SCHEMBL9304243 0.79 LAP3 (0.30) LAP3
SCHEMBL25670472 0.78
SCHEMBL25670443 0.78
SCHEMBL18193259 0.77
SCHEMBL21732705 0.75 LAP3 (0.32) LAP3
SCHEMBL20107347 0.74 CYP3A4 (0.35) LAP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667866-B2 Phosphorous containing compounds and uses thereof AFTON CHEMICAL CORPORATION (US) 2023-06-06 US disclosed
US-11667866-B2 Phosphorous containing compounds and uses thereof AFTON CHEMICAL CORPORATION (US) 2023-06-06 US disclosed
US-20210355408-A1 Phosphorous Containing Compounds and Uses Thereof AFTON CHEMICAL CORP (US) 2021-11-18 US disclosed
US-11066619-B2 Phosphorous containing compounds and uses thereof AFTON CHEMICAL CORPORATION (US) 2021-07-20 US disclosed
US-20200056114-A1 Phosphorous Containing Compounds and Uses Thereof AFTON CHEMICAL CORP (US) 2020-02-20 US disclosed
WO-2018081822-A1 PHOSPHOROUS CONTAINING COMPOUNDS AND USES THEREOF AFTON CHEMICAL CORPORATION (US) 2018-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210355408-A1 Phosphorous Containing Compounds and Uses Thereof SOST, PHOSPHO1, PSPH LAP3 3985/4885ANPEP 3688/4885ERAP1 2814/4885
US-20200056114-A1 Phosphorous Containing Compounds and Uses Thereof SOST, PHOSPHO1, PSPH LAP3 3985/4885ANPEP 3688/4885ERAP1 2814/4885
US-11667866-B2 Phosphorous containing compounds and uses thereof SOST, PHOSPHO1, PSPH LAP3 3985/4885ANPEP 3688/4885ERAP1 2814/4885
US-11066619-B2 Phosphorous containing compounds and uses thereof SOST, PHOSPHO1, PSPH LAP3 3985/4885ANPEP 3688/4885ERAP1 2814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.